• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床神经科学进展:帕金森病痴呆与路易体痴呆

Progress in clinical neurosciences: Parkinson's disease with dementia and dementia with Lewy bodies.

作者信息

Camicioli Richard, Fisher Nancy

机构信息

Department of Medicine, Division of Neurology, University of Alberta, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada.

出版信息

Can J Neurol Sci. 2004 Feb;31(1):7-21. doi: 10.1017/s0317167100002791.

DOI:10.1017/s0317167100002791
PMID:15038467
Abstract

Dementia occurs in up to 30% of people with Parkinson's disease and is a major cause of disability. Pathologically, Parkinson's dementia, where dementia follows the onset of parkinsonism by at least one year, overlaps with dementia with Lewy bodies. We review the functional impact, definitions, neuropsychology, epidemiology and pathophysiology of Parkinson's dementia, dementia with Lewy bodies and their overlap. Associated psychiatric and imaging findings are also considered. Lastly, current and emerging approaches to assessment and treatment in patients with these Lewy body associated dementias are presented.

摘要

高达30%的帕金森病患者会出现痴呆症,这是导致残疾的主要原因。在病理学上,帕金森病痴呆(痴呆症在帕金森综合征发病至少一年后出现)与路易体痴呆症有重叠。我们综述了帕金森病痴呆、路易体痴呆及其重叠情况的功能影响、定义、神经心理学、流行病学和病理生理学。还考虑了相关的精神科和影像学发现。最后,介绍了目前以及新出现的针对这些路易体相关痴呆症患者的评估和治疗方法。

相似文献

1
Progress in clinical neurosciences: Parkinson's disease with dementia and dementia with Lewy bodies.临床神经科学进展:帕金森病痴呆与路易体痴呆
Can J Neurol Sci. 2004 Feb;31(1):7-21. doi: 10.1017/s0317167100002791.
2
Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities.路易体痴呆和帕金森病痴呆最好被视为两种不同的病症。
Int Psychogeriatr. 2009 Apr;21(2):213-6. doi: 10.1017/S1041610208008600. Epub 2009 Jan 28.
3
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?路易体痴呆和帕金森病痴呆是同一种疾病吗?
BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.
4
Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review.路易体痴呆的临床表现与鉴别诊断:综述
Int J Geriatr Psychiatry. 2014 Jun;29(6):569-76. doi: 10.1002/gps.4039. Epub 2013 Oct 21.
5
Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions.帕金森病、帕金森病痴呆和路易体痴呆的临床和神经病理学差异——当前问题和未来方向。
J Neurochem. 2019 Sep;150(5):467-474. doi: 10.1111/jnc.14698. Epub 2019 Apr 23.
6
Neuropathology of Lewy body disorders.路易体疾病的神经病理学
Brain Res Bull. 2009 Oct 28;80(4-5):203-10. doi: 10.1016/j.brainresbull.2009.06.018. Epub 2009 Jul 1.
7
Lewy Body Dementias.路易体痴呆症
Continuum (Minneap Minn). 2019 Feb;25(1):128-146. doi: 10.1212/CON.0000000000000685.
8
Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease.痴呆家族史:路易体痴呆和帕金森病性痴呆。
J Neuropsychiatry Clin Neurosci. 2006 Winter;18(1):113-6. doi: 10.1176/jnp.18.1.113.
9
New evidence on the management of Lewy body dementia.关于路易体痴呆管理的新证据。
Lancet Neurol. 2020 Feb;19(2):157-169. doi: 10.1016/S1474-4422(19)30153-X. Epub 2019 Sep 10.
10
Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity.帕金森病痴呆与路易体痴呆:同一疾病实体的不同方面。
Int Psychogeriatr. 2009 Apr;21(2):216-9. doi: 10.1017/S1041610208008612. Epub 2009 Jan 28.

引用本文的文献

1
Application of Wearable Technology in Clinical Walking and Dual Task Testing.可穿戴技术在临床步行及双重任务测试中的应用
J Transl Int Med. 2019 Oct 12;7(3):87-89. doi: 10.2478/jtim-2019-0019. eCollection 2019 Sep.
2
Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure. sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.
J Neural Transm (Vienna). 2010 Mar;117(3):353-67. doi: 10.1007/s00702-010-0370-2. Epub 2010 Jan 30.
3
Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.
阿尔茨海默病和路易体谱障碍中的胆碱酯酶抑制剂:新兴的药物遗传学故事。
Hum Genomics. 2009 Dec;4(2):91-106. doi: 10.1186/1479-7364-4-2-91.
4
Rivastigmine in Parkinson's disease dementia: profile report.
Drugs Aging. 2007;24(3):255-9. doi: 10.2165/00002512-200724030-00006.
5
Recognition and management of neuropsychiatric complications in Parkinson's disease.帕金森病神经精神并发症的识别与管理
CMAJ. 2006 Dec 5;175(12):1545-52. doi: 10.1503/cmaj.060542.
6
Rivastigmine: in Parkinson's disease dementia.卡巴拉汀:用于帕金森病痴呆。
CNS Drugs. 2006;20(9):739-47; discussion 748-50. doi: 10.2165/00023210-200620090-00003.